Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.

Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 24 5 2020
medline: 24 5 2020
entrez: 24 5 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41587-020-0563-7 PMID: 32444853
pubmed: 32444853
doi: 10.1038/s41587-020-0563-7
pii: 10.1038/s41587-020-0563-7
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

756

Commentaires et corrections

Type : ErratumFor

Auteurs

Annabelle Gérard (A)

HiFiBiO Therapeutics SAS, Paris, France.
ORCID: 0000-0003-0411-768X

Adam Woolfe (A)

HiFiBiO Therapeutics SAS, Paris, France.

Guillaume Mottet (G)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.

Marcel Reichen (M)

HiFiBiO Therapeutics SAS, Paris, France.

Carlos Castrillon (C)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.
Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
ORCID: 0000-0003-2909-7371

Vera Menrath (V)

HiFiBiO Therapeutics SAS, Paris, France.

Sami Ellouze (S)

HiFiBiO Therapeutics SAS, Paris, France.

Adeline Poitou (A)

HiFiBiO Therapeutics SAS, Paris, France.

Raphaël Doineau (R)

HiFiBiO Therapeutics SAS, Paris, France.
École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.
Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.
ORCID: 0000-0003-0817-7778

Luis Briseno-Roa (L)

HiFiBiO Therapeutics SAS, Paris, France.
Medetia Pharma, Institut Imagine, Paris, France.

Pablo Canales-Herrerias (P)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.
Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
ORCID: 0000-0002-1865-6476

Pascaline Mary (P)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.

Gregory Rose (G)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.

Charina Ortega (C)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.
ORCID: 0000-0002-8814-8629

Matthieu Delincé (M)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.
ORCID: 0000-0001-8052-7918

Sosthene Essono (S)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.

Bin Jia (B)

Pfizer, Cambridge, MA, USA.
Abbvie Bioresearch Center, Worcester, MA, USA.

Bruno Iannascoli (B)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.

Odile Richard-Le Goff (O)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.

Roshan Kumar (R)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.

Samantha N Stewart (SN)

HiFiBiO Therapeutics Inc., Cambridge, MA, USA.

Yannick Pousse (Y)

HiFiBiO Therapeutics SAS, Paris, France.

Bingqing Shen (B)

HiFiBiO Therapeutics SAS, Paris, France.

Kevin Grosselin (K)

HiFiBiO Therapeutics SAS, Paris, France.
Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.

Baptiste Saudemont (B)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.

Antoine Sautel-Caillé (A)

Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
ORCID: 0000-0003-3899-3020

Alexei Godina (A)

Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.

Scott McNamara (S)

HiFiBiO Therapeutics SAS, Paris, France.

Klaus Eyer (K)

Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.
ORCID: 0000-0001-9344-5110

Gaël A Millot (GA)

Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.
ORCID: 0000-0002-0591-3509

Jean Baudry (J)

Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
ORCID: 0000-0002-5526-499X

Patrick England (P)

Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.
Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.

Clément Nizak (C)

Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
ORCID: 0000-0002-4591-8240

Allan Jensen (A)

HiFiBiO Therapeutics SAS, Paris, France.
Lundbeck A/S, Valby, Denmark.

Andrew D Griffiths (AD)

Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.
ORCID: 0000-0002-0808-3539

Pierre Bruhns (P)

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.
ORCID: 0000-0002-4709-8936

Colin Brenan (C)

HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.
HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.
1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.
ORCID: 0000-0002-9570-6166

Classifications MeSH